This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Transcranial Magnetic Stimulation in Depression

This study has been completed.
Sponsor:
Information provided by:
VA Office of Research and Development
ClinicalTrials.gov Identifier:
NCT00018746
First received: July 3, 2001
Last updated: January 20, 2009
Last verified: December 2004
  Purpose
The study examines efficacy of repetitive transcranial magnetic stimulation in treating severely depressed patients who are medicated.

Condition Intervention Phase
Depression Device: repetitive transcranial magnetic stimulation Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind
Primary Purpose: Treatment
Official Title: Efficacy of Threshold vs. Subthreshold TMS in the Treatment of Depression

Further study details as provided by VA Office of Research and Development:

Study Start Date: July 1999
Estimated Study Completion Date: July 2001
Detailed Description:
Medicated, treatment resistant, depressed patients are randomized to active or sham repetitive transcranial magnetic stimulation (rTMS). Responding patients go into a six months follow-up period.
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
severe treatment-resistant depression
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00018746

Locations
United States, Connecticut
VA Connecticut Healthcare System
West Haven, Connecticut, United States, 06516
Sponsors and Collaborators
VA Office of Research and Development
Investigators
OverallOfficial: Ralph Hoffman
OverallOfficial: Dan Oren
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00018746     History of Changes
Other Study ID Numbers: MHBS-037-98S
Study First Received: July 3, 2001
Last Updated: January 20, 2009

Additional relevant MeSH terms:
Depression
Depressive Disorder
Behavioral Symptoms
Mood Disorders
Mental Disorders

ClinicalTrials.gov processed this record on June 23, 2017